shopping cart Your cart is empty
  • Home
  • Healthcare
  • Allergy Diagnostics And Therapeutics Market By Types (Food, Inhaled), By Products (Assay Kits, Consumables, Instruments),By End Us...

Allergy Diagnostics And Therapeutics Market By Types (Food, Inhaled), By Products (Assay Kits, Consumables, Instruments),By End Users (Academic Research Centers, Diagnostic Laboratories, Hospitals), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: May 5, 2016

Key Findings


The Allergy Diagnostics and Therapeuticsmarketis expected to grow with CAGR of 12.67% in period of 2015-2022. The major factors that are driving the global Allergy Diagnostics and therapeutics market are increasing allergic diseases, growing IVD markets, increasing healthcare expenditure and increasing laboratory automation. Increasing respiratory allergic cases day by day increased the market of allergy diagnostics and therapeutics. According to American Academy of Allergy Asthma and Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide.


Market Segment Insight


The market is mainly segmented on the basisof types, product and end users. On the basis of types, the market is further segmented as food, inhaled and others. On the basis of product the market is further segmented as assay kits, consumables and instruments.On the basis of end users the market is further segmented asacademic research centers, diagnostic laboratories, hospitals and other end users. Hospitals are the largest consumers of allergy diagnostic products. It is expected that this segment will grow with CAGR of over 11% in future years.


Regional Insight


Based on types, product and end usersthe market is segmented into North America, Europe, APAC and RoW. North America holds thelargest market share ofallergy diagnostics and therapeutics and is followed by Europe. Due to advance technology and high investments in medical sector is helping to grow the market. In addition to this every thirteen children having age of 18 years in U.S. is suffering from some or the other allergic problems. In Europe, there are more than 17 million cases of food allergy and there have been seven times rise in allergic problem of children over the past decades


Competitive Insight


Some of the major market players are Allercheck Laboratories, Inc., BioMerieux SA, Danaher Corporation, Hitachi Chemical Diagnostics, Inc., HOB Biotech Group Co., Ltd., HYCOR BioMedical, Lincoln Diagnostics, Inc., Omega Diagnostics Group plc, Siemens Healthcare, Stallergenes, and Thermo Fisher Scientific, Inc.Acquisitions, technological advancements and mergers are the key strategies adopted by the market players to sustain in the market For example :MeDALL allergen is a chip which helps to determine allergies and helps to increase allergy diagnostics and therapeutics market globally. In 2015, Japan Stallergenes received approval for STG 320 which is the first tablet used in the treatment of house dust mite allergy.

CHAP 1.METHODOLOGY & SCOPE13
1.1.RESEARCH METHODOLOGY13
1.2.RESEARCH SCOPE & ASSUMPTIONS13
1.3.LIST OF DATA SOURCES13


CHAP 2.EXECUTIVE SUMMARY14
2.1.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET SUMMARY & KEY BUYING CRITERIA14
2.2.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET OUTLOOK14
2.3.MARKET SEGMENTATION ANALYSIS14
2.4.MARKET SIZE AND GROWTH PROSPECTS 2012-202214
2.5.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET VALUE CHAIN ANALYSIS14
2.6.VENDOR LANDSCAPE14


CHAP 3.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET15
3.1.MARKET DRIVER ANALYSIS15
3.2.MARKET RESTRAINT ANALYSIS15
3.3.KEY OPPORTUNITIES15
3.4.CHALLENGES15


CHAP 4.INDUSTRY ANALYSIS16
4.1.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET– PORTER’S FIVE FORCE MODEL16
4.2.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET– PESTEL ANALYSIS16
4.3.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET– GAP ANALYSIS16


CHAP 5.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY TYPES 2012-2022 ($ BILLION)17
5.1.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY FOOD 2012-2022 ($ BILLION)17
5.2.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY INHALED 2012-2022 ($ BILLION)17
5.3.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY OTHERS 2012-2022 ($ BILLION)17


CHAP 6.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY PRODUCTS 2012-2022 ($ BILLION)18
6.1.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY ASSAY KITS 2012-2022 ($ BILLION)18
6.2.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY CONSUMABLES 2012-2022 ($ BILLION)18
6.3.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY INSTRUMENTS 2012-2022 ($ BILLION)18


CHAP 7.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY END USERS 2012-2022 ($ BILLION)19
7.1.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY ACADEMIC RESEARCH CENTERS 2012-2022 ($ BILLION)19
7.2.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY DIAGNOSTIC LABORATORIES 2012-2022 ($ BILLION)19
7.3.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY HOSPITALS 2012-2022 ($ BILLION)19
7.4.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY OTHER END USERS 2012-2022 ($ BILLION)19


CHAP 8.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, REGIONAL OUTLOOK 2012-2022 ($ BILLION)20
8.1.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY REGION 2012-2022 ($ BILLION)20
8.2.NORTH AMERICA20
8.2.1.NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)20
8.2.2.NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION)20
8.2.3.NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)20
8.2.3.1.U.S.20
8.2.3.1.1.U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)20
8.2.3.1.2.U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)20
8.2.3.2.CANADA20
8.2.3.2.1.CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)20
8.2.3.2.2.CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)20
8.2.3.3.MEXICO20
8.2.3.3.1.MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)20
8.2.3.3.2.MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)20
8.3.EUROPE21
8.3.1.EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)21
8.3.2.EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION)21
8.3.3.EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)21
8.3.3.1.GERMANY21
8.3.3.1.1.GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)21
8.3.3.1.2.GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)21
8.3.3.2.UK21
8.3.3.2.1.UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)21
8.3.3.2.2.UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)21
8.3.3.3.FRANCE21
8.3.3.3.1.FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)22
8.3.3.3.2.FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)22
8.3.3.3.3.SPAIN22
8.3.3.3.4.SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)22
8.3.3.3.5.SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)22
8.3.3.3.6.ITALY22
8.3.3.3.7.ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)22
8.3.3.3.8.ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)22
8.3.3.4.REST OF EUROPE22
8.3.3.4.1.RUSSIA MARKET ESTIMATES AND FORECAST2012-2022($BILLION)22
8.3.3.4.2.OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION)22
8.4.ASIA PACIFIC22
8.4.1.ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)22
8.4.2.ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION)22
8.4.3.ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)22
8.4.3.1.CHINA22
8.4.3.1.1.CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)22
8.4.3.1.2.CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)22
8.4.3.2.INDIA22
8.4.3.2.1.INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)23
8.4.3.2.2.INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)23
8.4.3.3.JAPAN23
8.4.3.3.1.JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)23
8.4.3.3.2.JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION)23
8.4.3.4.AUSTRALIA23
8.4.3.4.1.AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)23
8.4.3.4.2.AUSTRALIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION)23
8.4.3.5.OTHERS23
8.4.3.5.1.OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION)23
8.4.3.5.2.OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION)23
8.5.REST OF THE WORLD23
8.5.1.MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)23
8.5.2.MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)23
8.5.3.SOUTH AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION)23
8.5.4.SOUTH AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION)23


CHAP 9.COMPETITIVE LANDSCAPE24
9.1.ALCON LABORATORIES25
9.2.25
9.2.1.COMPANY OVERVIEW25
9.2.2.SCOT ANALYSIS25
9.2.3.PRODUCT BENCHMARKING25
9.2.4.STRATEGIC INITIATIVES25
9.3.ALLERCHECK, INC.25
9.4.25
9.4.1.COMPANY OVERVIEW25
9.4.2.SCOT ANALYSIS25
9.4.3.PRODUCT BENCHMARKING25
9.4.4.STRATEGIC INITIATIVES25
9.5.BIOMERIEUX25
9.6.25
9.6.1.COMPANY OVERVIEW25
9.6.2.SCOT ANALYSIS25
9.6.3.PRODUCT BENCHMARKING25
9.6.4.STRATEGIC INITIATIVES25
9.7.DANAHER CORPORATION25
9.8.25
9.8.1.COMPANY OVERVIEW25
9.8.2.SCOT ANALYSIS25
9.8.3.PRODUCT BENCHMARKING25
9.8.4.STRATEGIC INITIATIVES25
9.9.HOB BIOTECH GROUP25
9.9.1.COMPANY OVERVIEW25
9.9.2.SCOT ANALYSIS26
9.9.3.PRODUCT BENCHMARKING26
9.9.4.STRATEGIC INITIATIVES26
9.10.HITACHI CHEMICAL DIAGNOSTICS26
9.11.26
9.11.1.COMPANY OVERVIEW26
9.11.2.SCOT ANALYSIS26
9.11.3.PRODUCT BENCHMARKING26
9.11.4.STRATEGIC INITIATIVES26
9.12.HOB BIOTECH GROUP26
9.13.26
9.13.1.COMPANY OVERVIEW26
9.13.2.SCOT ANALYSIS26
9.13.3.PRODUCT BENCHMARKING26
9.13.4.STRATEGIC INITIATIVES26
9.14.HYCOR BIOMEDICAL26
9.15.26
9.15.1.COMPANY OVERVIEW26
9.15.2.SCOT ANALYSIS26
9.15.3.PRODUCT BENCHMARKING26
9.15.4.STRATEGIC INITIATIVES26
9.16.LINCOLN DIAGNOSTICS26
9.17.26
9.17.1.COMPANY OVERVIEW26
9.17.2.SCOT ANALYSIS26
9.17.3.PRODUCT BENCHMARKING26
9.17.4.STRATEGIC INITIATIVES27
9.18.NIDEC CORP 27
9.18.1.COMPANY OVERVIEW27
9.18.2.SCOT ANALYSIS27
9.18.3.PRODUCT BENCHMARKING27
9.18.4.STRATEGIC INITIATIVES27
9.19.OMEGA DIAGNOSTICS27
9.20.27
9.20.1.COMPANY OVERVIEW27
9.20.2.SCOT ANALYSIS27
9.20.3.PRODUCT BENCHMARKING27
9.20.4.STRATEGIC INITIATIVES27
9.21.SIEMENS HEALTHCARE27
9.21.1.COMPANY OVERVIEW27
9.21.2.SCOT ANALYSIS27
9.21.3.PRODUCT BENCHMARKING27
9.21.4.STRATEGIC INITIATIVES27
9.22.STALLERGENES27
9.22.1.COMPANY OVERVIEW27
9.22.2.SCOT ANALYSIS27
9.22.3.PRODUCT BENCHMARKING27
9.22.4.STRATEGIC INITIATIVES27
9.23.THERMO FISHER SCIENTIFIC27
9.24.27
9.24.1.COMPANY OVERVIEW27
9.24.2.SCOT ANALYSIS28
9.24.3.PRODUCT BENCHMARKING28
9.24.4.STRATEGIC INITIATIVES28
9.25.28
9.25.1.COMPANY OVERVIEW28
9.25.2.SCOT ANALYSIS28
9.25.3.PRODUCT BENCHMARKING28
9.25.4.STRATEGIC INITIATIVES28

TABLE 1 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY TYPES 2012-2022 ($ BILLION) 28
TABLE 2 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY FOOD 2012-2022 ($ BILLION) 28
TABLE 3 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY INHALED 2012-2022 ($ BILLION) 28
TABLE 4 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY OTHERS 2012-2022 ($ BILLION) 28
TABLE 5 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY PRODUCTS 2012-2022 ($ BILLION) 28
TABLE 6 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY ASSAY KITS 2012-2022 ($ BILLION) 28
TABLE 7 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY CONSUMABLES 2012-2022 ($ BILLION) 28
TABLE 8 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY INSTRUMENTS COSMETICS 2012-2022 ($ BILLION) 28
TABLE 9 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY END USERS 2012-2022 ($ BILLION) 28
TABLE 10 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY ACADEMIC RESEARCH CENTERS 2012-2022 ($ BILLION) 28
TABLE 11 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY DIAGNOSTIC LABORATORIES 2012-2022 ($ BILLION) 29
TABLE 12 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY HOSPITALS 2012-2022 ($ BILLION) 29
TABLE 13 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY OTHER END USERS 2012-2022 ($ BILLION) 29
TABLE 14 GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY REGION 2012-2022 ($ BILLION) 29
TABLE 15 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 16 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 29
TABLE 17 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 18 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 19 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 20 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 21 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 22 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 23 MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 24 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 25 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 29
TABLE 26 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 27 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 28 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 30
TABLE 29 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
TABLE 30 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 30
TABLE 31 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
TABLE 32 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 30
TABLE 33 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
TABLE 34 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 30
TABLE 35 ITALY MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 30
TABLE 36 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
TABLE 37 OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 30
TABLE 38 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
TABLE 39 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 30
TABLE 40 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 30
TABLE 41 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
TABLE 42 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 30
TABLE 43 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
TABLE 44 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 30
TABLE 45 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
TABLE 46 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 31
TABLE 47 AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
TABLE 48 AUSTRALIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 31
TABLE 49 OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 31
TABLE 50 OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 31
TABLE 51 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
TABLE 52 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 31
TABLE 53 SOUTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 31

FIGURE 1 MARKET SHARE BY REGIONS 31
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32
FIGURE 9 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32
FIGURE 10 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32
FIGURE 11 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32
FIGURE 12 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32
FIGURE 13 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32
FIGURE 14 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32
FIGURE 15 AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32
FIGURE 16 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32
FIGURE 17 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32
FIGURE 18 SOUTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)